[ad_1]
Signage is seen exterior of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, U.S., August 29, 2020. REUTERS/Andrew Kelly/File Photo Acquire Licensing Rights
HYDERABAD, Dec 5 (Reuters) – India’s Dr Reddy’s (REDY.NS) on Tuesday mentioned that its analysis and improvement centre in Hyderabad is being inspected by the U.S. Food and Drug Administration.
“We confirm the commencement of a USFDA inspection at our R&D centre (Integrated Product Development Organisation or IPDO),” a Reddy’s spokesperson advised Reuters.
Reporting by Rishika Sadam in Hyderabad; Editing by Sonia Cheema
Our Standards: The Thomson Reuters Trust Principles.
[adinserter block=”4″]
[ad_2]
Source link